Study Title

Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG)

Study Details

Description:

The purpose of this study is to see if 18F-fluciclovine (Axumin®) PET imaging is useful and safe in the management of children with High Grade Gliomas. Investigators seek to determine if this imaging will help doctors tell the difference between tumor growth (progression) and other tumor changes that can occur after treatment.

Sponsor:

Children's Hospital of Philadelphia

Contacts:

Ali Nabavizadeh (Principal Investigator)

nabavizadehs@chop.edu

215-590-1000

Hannah Anderson

hannah.anderson@pennmedicine.upenn.edu

215-590-1000